Skip to main content
Evome Medical Technologies Inc. logo

Evome Medical Technologies Inc. — Investor Relations & Filings

Ticker · EVMT ISIN · CA30053H1055 TSXV Manufacturing
Open in API
Filings indexed 403 across all filing types
Latest filing 2023-01-12 Call Transcript
Country CA Canada
Listing TSXV EVMT

About Evome Medical Technologies Inc.

https://www.evomemedical.com

Evome Medical Technologies Inc. is a medical device enterprise dedicated to the design, development, production, and distribution of specialized medical devices. The company's core business centers on human performance and rehabilitative solutions, specifically addressing the post-operative and recovery market. Evome aims to enhance patient outcomes through its portfolio of devices utilized in rehabilitation settings.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Call Transcript Classification · 90% confidence The document is a short announcement about an upcoming earnings conference call for the third quarter 2022 financial results. It includes details about the call date, time, and dial-in information but does not contain any actual financial data or results. The document length is only 954 characters, indicating it is a brief notice rather than a full report or transcript. Therefore, it fits the category of a Call Transcript (CT) announcement, but since it does not contain the transcript itself, it is best classified as a Regulatory Filing (RNS) as a general announcement. However, given the specific nature of the announcement about the earnings call, the best fit is Call Transcript (CT) as it is directly related to the earnings call event.
2023-01-12 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing Salona Global's strategic decision to focus on listing on the Nasdaq Capital Market in 2023, including a change in fiscal year end and withdrawal of a Canadian debenture offering. It discusses corporate strategy, capital market focus, and acquisition plans but does not contain any financial statements, detailed financial performance data, or regulatory filings. It is an update on capital market activities and financing strategy rather than a formal financial report or regulatory filing. Therefore, it fits best under Capital/Financing Update (CAP). The document length (8405 characters) and content confirm it is not a brief announcement or a certification but a substantive update on financing and capital market plans.
2022-12-15 English
Other.pdf
Regulatory Filings
2022-12-08 English
Other.pdf
Regulatory Filings
2022-12-08 English
Other.pdf
Regulatory Filings
2022-12-08 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a private placement offering of debenture units by Salona Global Medical Device Corporation. It details the terms of the offering, including the amount, pricing, maturity, interest rate, and use of proceeds. The document also includes disclaimers about securities registration and forward-looking statements. There is no financial report, earnings data, or management discussion of financial results. The content focuses on a financing activity, specifically a private placement of debt securities. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length is sufficient and contains substantive details about the financing, not just an announcement of a report or a regulatory filing. Hence, the classification is CAP with high confidence.
2022-12-01 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.